An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

Complicating matters, however, were new FDA rules for the updated Covid vaccines, announced just days earlier, that would ...

U.S. senators questioned the head of the FDA today about who will be eligible for a COVID-19 booster in the fall. The agency ...

【5月21日 ...

健康な成人と子どもを対象とした新型コロナウイルス感染症のブースター接種について、米規制当局は今後、新たな臨床試験で安全性と有効性が確認されることを承認の条件とする。コストのかかる新要件が追加され、将来的にはワクチン接種対象者が絞られる可能性もある。